Wilhelmus Groenhuysen
2017
In 2017, Wilhelmus Groenhuysen earned a total compensation of $3.1M as Chief Financial Officer at NovoCure, a 50% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $360,360 |
|---|---|
| Option Awards | $1,195,857 |
| Salary | $600,600 |
| Stock Awards | $929,500 |
| Other | $30,765 |
| Total | $3,117,082 |
Groenhuysen received $1.2M in option awards, accounting for 38% of the total pay in 2017.
Groenhuysen also received $360.4K in non-equity incentive plan, $600.6K in salary, $929.5K in stock awards and $30.8K in other compensation.
Rankings
In 2017, Wilhelmus Groenhuysen's compensation ranked 3,470th out of 14,666 executives tracked by ExecPay. In other words, Groenhuysen earned more than 76.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,470 out of 14,666 | 76th |
Division Manufacturing | 1,197 out of 5,772 | 79th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 156 out of 859 | 82nd |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 84 out of 531 | 84th |
Industry Surgical and Medical Instruments and Apparatus | 53 out of 336 | 84th |
Source: SEC filing on April 20, 2018.
Groenhuysen's colleagues
We found four more compensation records of executives who worked with Wilhelmus Groenhuysen at NovoCure in 2017.